Aprajita Nakra Dpm Pc - Medicare Podiatrist in Gilbert, AZ

Aprajita Nakra Dpm Pc is a medicare enrolled "Podiatrist" provider in Gilbert, Arizona. Their current practice location is 2915 E Baseline Rd, Suite 103, Gilbert, Arizona. You can reach out to their office (for appointments etc.) via phone at (480) 962-4281.

Aprajita Nakra Dpm Pc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Aprajita Nakra Dpm Pc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1225074206.

Contact Information

Aprajita Nakra Dpm Pc
2915 E Baseline Rd, Suite 103,
Gilbert, AZ 85234-2425
(480) 962-4281
Not Available



Healthcare Provider's Profile

Full NameAprajita Nakra Dpm Pc
TypeFacility
SpecialityPodiatrist
Location2915 E Baseline Rd, Gilbert, Arizona
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1225074206
  • Provider Enumeration Date: 06/20/2006
  • Last Update Date: 01/13/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 0749257293
  • Enrollment ID: O20040914000521

Medical Identifiers

Medical identifiers for Aprajita Nakra Dpm Pc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1225074206NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
213E00000XPodiatrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Aprajita Nakra Dpm Pc acts as a billing entity for following providers:
Provider NameBruce W Krell
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1831149103
PECOS PAC ID: 0244126498
Enrollment ID: I20040224001256

News Archive

Natural products: The source of nearly half of modern drugs

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Research progress with promising Alzheimer's drug Xanamem

Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.

Women in science: an interview with Professor Dame Carol Robinson, University of Oxford

Professor Dame Carol Robinson has just been announced as the "L'Oréal-UNESCO For Women In Science" European Laureate for 2015...

Scidev.net feature addresses nutrition, food security

SciDev.net includes a special feature on the challenges associated with meeting the nutritional and food needs of people around the world.

Federal speech rulings may embolden health care workers to call out safety issues

Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital where she worked as an activities coordinator, arguing that their actions led to staffing shortages and other patient safety problems.

Read more Medical News

› Verified 7 days ago

Provider NameVu T Nguyen
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1457675126
PECOS PAC ID: 8426236209
Enrollment ID: I20110627000168

News Archive

Natural products: The source of nearly half of modern drugs

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Research progress with promising Alzheimer's drug Xanamem

Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.

Women in science: an interview with Professor Dame Carol Robinson, University of Oxford

Professor Dame Carol Robinson has just been announced as the "L'Oréal-UNESCO For Women In Science" European Laureate for 2015...

Scidev.net feature addresses nutrition, food security

SciDev.net includes a special feature on the challenges associated with meeting the nutritional and food needs of people around the world.

Federal speech rulings may embolden health care workers to call out safety issues

Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital where she worked as an activities coordinator, arguing that their actions led to staffing shortages and other patient safety problems.

Read more Medical News

› Verified 7 days ago

Provider NameJessica L Prebish
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1407185093
PECOS PAC ID: 7719137306
Enrollment ID: I20121016000584

News Archive

Natural products: The source of nearly half of modern drugs

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Research progress with promising Alzheimer's drug Xanamem

Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.

Women in science: an interview with Professor Dame Carol Robinson, University of Oxford

Professor Dame Carol Robinson has just been announced as the "L'Oréal-UNESCO For Women In Science" European Laureate for 2015...

Scidev.net feature addresses nutrition, food security

SciDev.net includes a special feature on the challenges associated with meeting the nutritional and food needs of people around the world.

Federal speech rulings may embolden health care workers to call out safety issues

Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital where she worked as an activities coordinator, arguing that their actions led to staffing shortages and other patient safety problems.

Read more Medical News

› Verified 7 days ago

Provider NameMelissa J Ries
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1790195964
PECOS PAC ID: 1052683356
Enrollment ID: I20170822001475

News Archive

Natural products: The source of nearly half of modern drugs

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Research progress with promising Alzheimer's drug Xanamem

Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.

Women in science: an interview with Professor Dame Carol Robinson, University of Oxford

Professor Dame Carol Robinson has just been announced as the "L'Oréal-UNESCO For Women In Science" European Laureate for 2015...

Scidev.net feature addresses nutrition, food security

SciDev.net includes a special feature on the challenges associated with meeting the nutritional and food needs of people around the world.

Federal speech rulings may embolden health care workers to call out safety issues

Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital where she worked as an activities coordinator, arguing that their actions led to staffing shortages and other patient safety problems.

Read more Medical News

› Verified 7 days ago

Provider NameBrent Richard Weintrub
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1043694235
PECOS PAC ID: 2668720889
Enrollment ID: I20180803003004

News Archive

Natural products: The source of nearly half of modern drugs

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Research progress with promising Alzheimer's drug Xanamem

Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.

Women in science: an interview with Professor Dame Carol Robinson, University of Oxford

Professor Dame Carol Robinson has just been announced as the "L'Oréal-UNESCO For Women In Science" European Laureate for 2015...

Scidev.net feature addresses nutrition, food security

SciDev.net includes a special feature on the challenges associated with meeting the nutritional and food needs of people around the world.

Federal speech rulings may embolden health care workers to call out safety issues

Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital where she worked as an activities coordinator, arguing that their actions led to staffing shortages and other patient safety problems.

Read more Medical News

› Verified 7 days ago

Provider NameAndrew G Levitt
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1760773220
PECOS PAC ID: 6103112552
Enrollment ID: I20180913001187

News Archive

Natural products: The source of nearly half of modern drugs

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Research progress with promising Alzheimer's drug Xanamem

Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.

Women in science: an interview with Professor Dame Carol Robinson, University of Oxford

Professor Dame Carol Robinson has just been announced as the "L'Oréal-UNESCO For Women In Science" European Laureate for 2015...

Scidev.net feature addresses nutrition, food security

SciDev.net includes a special feature on the challenges associated with meeting the nutritional and food needs of people around the world.

Federal speech rulings may embolden health care workers to call out safety issues

Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital where she worked as an activities coordinator, arguing that their actions led to staffing shortages and other patient safety problems.

Read more Medical News

› Verified 7 days ago

Provider NameMathew A Cline
Provider TypePractitioner - Podiatry
Provider IdentifiersNPI Number: 1699193250
PECOS PAC ID: 6800011800
Enrollment ID: I20200504002492

News Archive

Natural products: The source of nearly half of modern drugs

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Research progress with promising Alzheimer's drug Xanamem

Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.

Women in science: an interview with Professor Dame Carol Robinson, University of Oxford

Professor Dame Carol Robinson has just been announced as the "L'Oréal-UNESCO For Women In Science" European Laureate for 2015...

Scidev.net feature addresses nutrition, food security

SciDev.net includes a special feature on the challenges associated with meeting the nutritional and food needs of people around the world.

Federal speech rulings may embolden health care workers to call out safety issues

Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital where she worked as an activities coordinator, arguing that their actions led to staffing shortages and other patient safety problems.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Aprajita Nakra Dpm Pc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Aprajita Nakra Dpm Pc
2915 E Baseline Rd, Suite 103,
Gilbert, AZ 85234-2425

Ph: (480) 962-4281
Aprajita Nakra Dpm Pc
2915 E Baseline Rd, Suite 103,
Gilbert, AZ 85234-2425

Ph: (480) 962-4281

News Archive

Natural products: The source of nearly half of modern drugs

New technology for discovering antibiotics, anti-cancer drugs and other medicines inside soil microbes and other natural sources is reviving a treasure hunt that already has given humanity more than 50 percent of today's prescription drugs. This new era in "bioprospecting" is the topic of the cover story in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society.

Research progress with promising Alzheimer's drug Xanamem

Actinogen Limited (Actinogen Medical, ASX: ACW), an Australian biotechnology company focused on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders, is pleased to announce that it has received ethics approval to initiate the third and final stage of the second Phase I trial of its lead Alzheimer's drug candidate, Xanamem™.

Women in science: an interview with Professor Dame Carol Robinson, University of Oxford

Professor Dame Carol Robinson has just been announced as the "L'Oréal-UNESCO For Women In Science" European Laureate for 2015...

Scidev.net feature addresses nutrition, food security

SciDev.net includes a special feature on the challenges associated with meeting the nutritional and food needs of people around the world.

Federal speech rulings may embolden health care workers to call out safety issues

Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital where she worked as an activities coordinator, arguing that their actions led to staffing shortages and other patient safety problems.

Read more News

› Verified 7 days ago


Podiatrist in Gilbert, AZ

Dr. Andrew Goodeill, DPM
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 4915 E Baseline Rd, Ste 121, Gilbert, AZ 85234
Phone: 480-812-3668    Fax: 480-782-1290
Mahsa Agha Jafari, DPM
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 4915 E Baseline Rd Ste 121, Gilbert, AZ 85234
Phone: 480-812-3668    Fax: 480-782-1290
Sun Valley Foot And Ankle Pllc
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 3336 E Chandler Heights Rd Ste 121, Gilbert, AZ 85298
Phone: 480-245-7027    
Dr. Robert Christopher Andersen, DPM
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 3336 E Chandler Heights Rd Ste 121, Gilbert, AZ 85298
Phone: 480-245-7027    
James E Schmidt, D.P.M.
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 2353 E Baseline Rd Ste 105, Gilbert, AZ 85234
Phone: 602-491-0701    
Spectrum Falls Foot & Ankle Specialists, Pc
Podiatrist
Medicare: Not Enrolled in Medicare
Practice Location: 2730 S Val Vista Dr, Suite 158, Gilbert, AZ 85296
Phone: 480-889-7055    Fax: 480-889-7054
Christopher Van Damme,
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 4915 E Baseline Rd Ste 121, Gilbert, AZ 85234
Phone: 480-812-6882    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.